Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Procalcitonin-guided Antibiotic Therapy in Aspiration Pneumonia
NCT02862314Phase 4Completed
- Sponsor
- CHU de Besançon
- Start
- Feb 2015
- Primary completion
- Nov 2019
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in aspiration pneumonia (2 arms), sponsored by CHU de Besançon. Primary endpoint: Duration of antibiotic treatment at 15 days. Started Feb 2015; status: completed.
02
Conditions
aspiration pneumonia
Beyond the preview
Go deeper on NCT02862314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02862314.